WO2007132120A3 - Procede et methodes de detection de la maladie d'alzheimer - Google Patents
Procede et methodes de detection de la maladie d'alzheimer Download PDFInfo
- Publication number
- WO2007132120A3 WO2007132120A3 PCT/FR2007/051263 FR2007051263W WO2007132120A3 WO 2007132120 A3 WO2007132120 A3 WO 2007132120A3 FR 2007051263 W FR2007051263 W FR 2007051263W WO 2007132120 A3 WO2007132120 A3 WO 2007132120A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disease
- alzheimer
- methods
- procedure
- mammals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002652258A CA2652258A1 (fr) | 2006-05-15 | 2007-05-14 | Procede et methodes de detection de la maladie d'alzheimer |
NZ573505A NZ573505A (en) | 2006-05-15 | 2007-05-14 | Procedure and methods for detecting alzheimer's disease |
CN2007800267862A CN101490280B (zh) | 2006-05-15 | 2007-05-14 | 检测阿尔茨海默病的试剂 |
AU2007251408A AU2007251408B2 (en) | 2006-05-15 | 2007-05-14 | Procedure and methods for detecting Alzheimer's disease |
JP2009510510A JP2009537133A (ja) | 2006-05-15 | 2007-05-14 | アルツハイマー病を検出するための手順および方法 |
US12/227,374 US20100055682A1 (en) | 2006-05-15 | 2007-05-14 | Procedure and methods for detecting alzheimers's disease |
EP07766039A EP2021509A2 (fr) | 2006-05-15 | 2007-05-14 | Procédé et méthodes de détection de la maladie d'alzheimer |
IL195288A IL195288A (en) | 2006-05-15 | 2008-11-13 | Methods for identifying Alzheimer's disease |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0604294 | 2006-05-15 | ||
FR0604294A FR2900936B1 (fr) | 2006-05-15 | 2006-05-15 | Procede et methodes de detection de la maladie d'alzheimer |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007132120A2 WO2007132120A2 (fr) | 2007-11-22 |
WO2007132120A3 true WO2007132120A3 (fr) | 2008-05-08 |
Family
ID=37496633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2007/051263 WO2007132120A2 (fr) | 2006-05-15 | 2007-05-14 | Procede et methodes de detection de la maladie d'alzheimer |
Country Status (12)
Country | Link |
---|---|
US (1) | US20100055682A1 (fr) |
EP (1) | EP2021509A2 (fr) |
JP (1) | JP2009537133A (fr) |
KR (1) | KR20090098941A (fr) |
CN (1) | CN101490280B (fr) |
AU (1) | AU2007251408B2 (fr) |
CA (1) | CA2652258A1 (fr) |
FR (2) | FR2900936B1 (fr) |
IL (1) | IL195288A (fr) |
NZ (1) | NZ573505A (fr) |
WO (1) | WO2007132120A2 (fr) |
ZA (1) | ZA200810528B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2929292A1 (fr) | 2008-03-28 | 2009-10-02 | Exonhit Therapeutics S A Sa | Procede et methodes de diagnostic de la maladie d'alzheimer |
ES2628944T3 (es) * | 2008-05-23 | 2017-08-04 | Mochida Pharmaceutical Co., Ltd. | Método para la evaluación de la función de fagocitos |
US20100099609A1 (en) * | 2008-07-28 | 2010-04-22 | Buck Institute For Age Research | eAPP AND DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE |
KR101295019B1 (ko) * | 2011-04-22 | 2013-08-09 | 경북대학교 산학협력단 | 리포칼린 2 수준을 측정하는 것을 포함하는 경도 인지 장애 진단용 조성물, 키트 및 경도인지 장애 진단을 위한 정보 제공방법. |
US9541561B2 (en) | 2012-06-14 | 2017-01-10 | Electronics And Telecommunications Research Institute | Method for diagnosing Alzheimer's disease using biomaterial |
EP2728015A1 (fr) * | 2012-10-31 | 2014-05-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédé pour le diagnostic du syndrome de Sézary |
WO2016024101A1 (fr) * | 2014-08-13 | 2016-02-18 | Timmons James Archibald | Diagnostic médical |
CN104328200B (zh) * | 2014-11-18 | 2016-04-06 | 宁波大学 | 辅助诊断阿尔茨海默病的检测试剂盒及其检测方法 |
WO2019049705A1 (fr) * | 2017-09-08 | 2019-03-14 | 自然免疫制御技術研究組合 | Dispositif et procédé de diagnostic de symptômes de la maladie d'alzheimer |
WO2023005959A1 (fr) * | 2021-07-27 | 2023-02-02 | The Hong Kong University Of Science And Technology | Compositions et méthodes de traitement de la maladie d'alzheimer |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0791660A1 (fr) * | 1996-02-22 | 1997-08-27 | Smithkline Beecham Corporation | Nouveau marqueur diagnostique pour variations d'épissage de gènes en association avec fonctions neurologiques |
WO2002008449A2 (fr) * | 2000-07-25 | 2002-01-31 | The Sir Mortimer B. Davis - Jewish General Hospital | Suppresseur de ho-1 utile comme test de diagnostic et de pronostic dans les maladies dementielles |
EP1479396A1 (fr) * | 2002-01-31 | 2004-11-24 | Celestar Lexico-Sciences, Inc. | Medicaments ameliorant les troubles du rythme circadien |
EP1491213A1 (fr) * | 2002-03-29 | 2004-12-29 | Celestar Lexico-Sciences, Inc. | Inhibiteurs de phosphorylation c-jun |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
GB0227238D0 (en) * | 2002-11-21 | 2002-12-31 | Diagenic As | Product and method |
-
2006
- 2006-05-15 FR FR0604294A patent/FR2900936B1/fr not_active Expired - Fee Related
-
2007
- 2007-05-14 CA CA002652258A patent/CA2652258A1/fr not_active Abandoned
- 2007-05-14 US US12/227,374 patent/US20100055682A1/en not_active Abandoned
- 2007-05-14 JP JP2009510510A patent/JP2009537133A/ja active Pending
- 2007-05-14 NZ NZ573505A patent/NZ573505A/en not_active IP Right Cessation
- 2007-05-14 EP EP07766039A patent/EP2021509A2/fr not_active Withdrawn
- 2007-05-14 AU AU2007251408A patent/AU2007251408B2/en not_active Ceased
- 2007-05-14 CN CN2007800267862A patent/CN101490280B/zh not_active Expired - Fee Related
- 2007-05-14 WO PCT/FR2007/051263 patent/WO2007132120A2/fr active Application Filing
- 2007-05-14 KR KR1020087030380A patent/KR20090098941A/ko not_active Application Discontinuation
-
2008
- 2008-11-13 IL IL195288A patent/IL195288A/en not_active IP Right Cessation
- 2008-12-11 ZA ZA200810528A patent/ZA200810528B/xx unknown
-
2012
- 2012-11-21 FR FR1261064A patent/FR2980484A1/fr not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0791660A1 (fr) * | 1996-02-22 | 1997-08-27 | Smithkline Beecham Corporation | Nouveau marqueur diagnostique pour variations d'épissage de gènes en association avec fonctions neurologiques |
WO2002008449A2 (fr) * | 2000-07-25 | 2002-01-31 | The Sir Mortimer B. Davis - Jewish General Hospital | Suppresseur de ho-1 utile comme test de diagnostic et de pronostic dans les maladies dementielles |
EP1479396A1 (fr) * | 2002-01-31 | 2004-11-24 | Celestar Lexico-Sciences, Inc. | Medicaments ameliorant les troubles du rythme circadien |
EP1491213A1 (fr) * | 2002-03-29 | 2004-12-29 | Celestar Lexico-Sciences, Inc. | Inhibiteurs de phosphorylation c-jun |
Non-Patent Citations (6)
Title |
---|
CARDINALI DANIEL P ET AL: "Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent.", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES DEC 2005, vol. 1057, December 2005 (2005-12-01), pages 327 - 336, XP002460021, ISSN: 0077-8923 * |
DATABASE GEO 11 March 2002 (2002-03-11), "Affymetrix GeneChip Human Genome U133 Array Set HG-U133A", XP002411782, retrieved from NCBI Database accession no. GPL96 * |
LIU R-Y ET AL: "DECREASED VASOPRESSIN GENE EXPRESSION IN THE BIOLOGICAL CLOCK OF ALZHEIMER DISEASE PATIENTS WITH AND WITHOUT DEPRESSION", JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, NEW YORK, NY, US, vol. 59, no. 4, April 2000 (2000-04-01), pages 314 - 322, XP009037740, ISSN: 0022-3069 * |
MINORETTI ET AL: "Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease", NEUROSCIENCE LETTERS, LIMERICK, IE, vol. 391, no. 3, 2 January 2006 (2006-01-02), pages 147 - 149, XP005191966, ISSN: 0304-3940 * |
TAKAHASHI NOBUYUKI ET AL: "Two novel spliced presenilin 2 transcripts in human lymphocyte with oxidant stress and brain.", MOLECULAR AND CELLULAR BIOCHEMISTRY, vol. 252, no. 1-2, October 2003 (2003-10-01), pages 279 - 283, XP002411664, ISSN: 0300-8177 * |
WU YING-HUI ET AL: "Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock".", THE FASEB JOURNAL : OFFICIAL PUBLICATION OF THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY SEP 2006, vol. 20, no. 11, September 2006 (2006-09-01), pages 1874 - 1876, XP002460022, ISSN: 1530-6860 * |
Also Published As
Publication number | Publication date |
---|---|
FR2980484A1 (fr) | 2013-03-29 |
US20100055682A1 (en) | 2010-03-04 |
CN101490280A (zh) | 2009-07-22 |
AU2007251408B2 (en) | 2012-11-29 |
ZA200810528B (en) | 2009-10-28 |
EP2021509A2 (fr) | 2009-02-11 |
KR20090098941A (ko) | 2009-09-18 |
JP2009537133A (ja) | 2009-10-29 |
FR2900936A1 (fr) | 2007-11-16 |
CA2652258A1 (fr) | 2007-11-22 |
NZ573505A (en) | 2011-04-29 |
FR2900936B1 (fr) | 2013-01-04 |
CN101490280B (zh) | 2012-09-26 |
WO2007132120A2 (fr) | 2007-11-22 |
AU2007251408A1 (en) | 2007-11-22 |
IL195288A (en) | 2013-10-31 |
IL195288A0 (en) | 2009-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007132120A3 (fr) | Procede et methodes de detection de la maladie d'alzheimer | |
WO2007048978A3 (fr) | Procede de detection du cancer | |
WO2007114947A3 (fr) | Système et procédés hautement sensibles destinés à une analyse de la troponine | |
WO2009144424A3 (fr) | Procede et methodes de diagnostic de la maladie d'alzheimer | |
WO2008021290A9 (fr) | Protéines spécifiques d'organes et procédés d'utilisation | |
WO2008020823A3 (fr) | Systèmes de rapporteur coopératifs, composants, et procédés pour une détection d'analyte | |
WO2010041892A3 (fr) | Nouvelle utilisation du polypeptide aimp1 | |
WO2006090389A3 (fr) | Nouveaux marqueurs diagnostiques, en particulier pour l'imagerie in vivo, et dosage et procedes d'utilisation associes | |
WO2007028161A3 (fr) | Procédés et compositions permettant d’identifier des biomarqueurs utiles au diagnostic et/ou au traitement d’états biologiques | |
AU2013207599A1 (en) | Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof | |
WO2008070865A3 (fr) | Matériaux et méthodes pour détecter efficacement et précisément des analytes | |
WO2002086448A3 (fr) | Detection de l'instabilite des microsatellites et son utilisation dans le diagnostic des tumeurs | |
WO2007092640A3 (fr) | Anticorps qui se lient à par-2 | |
WO2007010379A3 (fr) | Evaluation calorimetrique de micro-organismes et utilisation | |
WO2007117330A3 (fr) | Criblages de la protéine c latente et leurs usages pour le diagnostic et/ou le pronostic de syndromes de réponse inflammatoire systémique | |
WO2007114986A3 (fr) | Sondes coopératives et leurs procédés d'utilisation | |
WO2009007846A3 (fr) | Procédé pour modifier, isoler, détecter, visualiser et quantifier des peptides, polypeptides et protéines contenant de la citrulline et/ou de l'homocitrulline | |
WO2002022879A3 (fr) | Detection de l'instabilite des microsatellites et utilisation de celle-ci dans le diagnostic de tumeurs | |
WO2006086377A3 (fr) | Methode de detection de fievre porcine classique | |
WO2009120183A3 (fr) | Système pour la détection d’un pathogène biologique et utilisation de celui-ci | |
WO2007061988A3 (fr) | Procedes pour determiner une signalisation notch et utilisations de ceux-ci | |
WO2006099537A3 (fr) | Utilisation de systemes d'antigenes a substituts d'anticorps a des fins de detection d'analytes | |
PL376121A1 (pl) | Zestaw diagnostyczny do badania surowic zwierząt na obecność przeciwciał RHD oraz zestaw diagnostyczny do wykrywania wirusa RHD | |
WO2011109112A3 (fr) | Procédé de détection de la protéine tau et des fragments de tau dans le sérum | |
WO2009007649A3 (fr) | Dispositif et procede d'identification et de determination de groupes sanguins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780026786.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07766039 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2652258 Country of ref document: CA Ref document number: 2009510510 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 573505 Country of ref document: NZ Ref document number: 2007251408 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007766039 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2649/MUMNP/2008 Country of ref document: IN Ref document number: 1020087030380 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2007251408 Country of ref document: AU Date of ref document: 20070514 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12227374 Country of ref document: US |